>
Trump defends AG Pam Bondi amid Epstein file backlash: 'Let her do her job'
Metal fuses in space - with no heat or pressure
In case you missed it...AIRLINE GIANT EMIRATES TO ACCEPT BITCOIN AND CRYPTO FOR FLIGHTS
Pentagon to become largest shareholder in rare earth miner MP Materials; shares surge 50%
Magic mushrooms may hold the secret to longevity: Psilocybin extends lifespan by 57%...
Unitree G1 vs Boston Dynamics Atlas vs Optimus Gen 2 Robot– Who Wins?
LFP Battery Fire Safety: What You NEED to Know
Final Summer Solar Panel Test: Bifacial Optimization. Save Money w/ These Results!
MEDICAL MIRACLE IN JAPAN: Paralyzed Man Stands Again After Revolutionary Stem Cell Treatment!
Insulator Becomes Conducting Semiconductor And Could Make Superelastic Silicone Solar Panels
Slate Truck's Under $20,000 Price Tag Just Became A Political Casualty
Wisdom Teeth Contain Unique Stem Cell That Can Form Cartilage, Neurons, and Heart Tissue
Hay fever breakthrough: 'Molecular shield' blocks allergy trigger at the site
Authored by Joseph Brown via TheMindUnleashed.com,
The Food and Drug Administration authorized eye drops that may possibly replace reading glasses for millions of people in October, and they entered the market this week.
"It's definitely a life changer," trial participant Toni Wright told CBS.
"I would not need my readers as much, especially on the computer, where I would always need to have them on."
The drops, known as pilocarpine, and sold by pharma outlet Allergan under the name "Vuity," might help the 128 million people in the United States who are nearsighted.
One drop in each eye, according to the business, may enhance closeup eyesight for six to ten hours, according to CBS News.